Company news
Connect Biopharma Holdings Limited news in 2024
Connect Biopharma Holdings Limited's news releases, calls and decks from 2024, newest first.
Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update
September 4, 2024
Connect Biopharma Announces New Leadership and Chair of the Board of Directors
June 11, 2024
Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 11, 2024
Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma
May 21, 2024
Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma
May 6, 2024
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
April 15, 2024
Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors
February 11, 2024
Decks in 2024
- Technical Presentation (June 2024)
Technical · 9 slides · June 2024